In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818

European Journal of Pharmacology

Volumn 301, Issue 1-3, 1996, Pages 99-106

  Hattori, Yuichi ^a   Fukao, Mitsuhiro ^a   Houzen, Hideki ^a   Qi, Fazhi ^a   Yamada, Yoichi ^a   Kanno, Mono ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Ca2+ channel antagonist; Ca2+ current; L type; NB 818; Negative chronotropic action; Negative inotropic action; Vascular relaxation

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; LEMILDIPINE; NEW DRUG; NIFEDIPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CHRONOTROPISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ELECTRIC POTENTIAL; FEMALE; FEMORAL ARTERY; GUINEA PIG; HEART MUSCLE CELL; HEART PAPILLARY MUSCLE; HEART RIGHT ATRIUM; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE RELAXATION; VASODILATATION;

EID: 0029894926     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00007-6     Document Type: Article

References (33)

1. Bean, B.P., 1984, Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state, Proc. Natl. Acad. Sci. USA 81, 6388.
2. Bean, B.P., M. Sturek, A. Puga and K. Hermsmeyer, 1986, Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs. Circ. Res. 59, 229.
3. Bossert, F., H. Horstmann, H. Meyer and W. Vater, 1979, Einfluß der Esterfunktion auf die vasodilatierenden Eigenschaften von 1,4-Dihydro-2,6-dimethyl-4-nitrophenyl-pyridin-3,5-dicarbonsäure-estern, Arzneim.-Forsch. 29, 226.
4. Burges, R.A., A.J. Carter, D.G. Gardiner and A.J. Higgins, 1985, Amlodipine, a new dihydropyridine calcium channel blocker with slow onset and long duration of action, Br. J. Pharmacol. 85 (Suppl.), 281P.
5. Diez, I., H. Colom, J. Moreno, R. Obach, C. Peraire and J. Domenech, 1991. A comparative in vitro study of trandermal absorption of a series of calcium channel antagonist, J. Pharm. Sci. 80, 931.
6. Godfraind, T., M. Finet, J.S. Lima and R.C. Miller, 1984, Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine. J. Pharmacol. Exp. Ther. 230, 514.
7. Godfraind, T., R. Miller and M. Wibo, 1986, Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38, 321.
8. 2+ agonists and antagonists, Nature 311, 538.
9. Hof, R.P., 1987. Comparison of cardiodepressant and vasodilator effects of PN200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits, Am. J. Cardiol. 59, 37B.
10. Hondeghem, L.M. and B.G. Katzung, 1984. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs, Annu. Rev. Pharmacol. Toxicol. 24, 387.
11. 2+-antagonist, to the calcium channel of rat brain membrane, Jpn. J. Pharmacol. 46 (Suppl.), 298P.
12. Kazda, S., A. Knorr and R. Towart, 1983, Common properties and differences between various calcium antagonists, Prog. Pharmacol. 5, 83.
13. Kwan, Y.W., R. Bangalore, M. Lakitsh, H. Glossmann and R.S. Kass, 1995. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implication for pharmacokinetics and access to dihydropyridine binding site. J. Mol. Cell. Cardiol. 27, 253.
14. Masuda, Y., M. Takeguchi, C. Arakawa, T. Sakai, M. Hibi, S. Tanaka, K. Shigenobu and Y. Kasuya, 1990, Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative, Arch. Int. Pharmacodyn. Ther. 304, 247.
15. Micheli, D., A. Collodel, C. Semeraro, G. Gaviraghi and C. Carpi, 1990, Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies, J. Cardiovasc. Pharmacol. 15, 666.
16. Nagura, J., K. Suzuki, K. Shiratori, T. Fukuroda, M. Nishikibe, B. Murayama and K. Takeya, 1989, Comparison of the cardiovascular effects of three dihydropyridine compounds. Arch. Int. Pharmacodyn. Ther. 302, 174.
17. Nakaya, H., Y. Hattori, N. Tohse and M. Kanno, 1986. Voltage-dependent effects of YC-170, a dihyropyridine calcium channel modulator, in cardiovascular tissues. Naunyn-Schmied. Arch. Pharmacol. 333, 421.
18. Nakaya, H., Y. Hattori, Y. Nakao and M. Kanno, 1988, Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists, Eur. J. Pharmacol. 146, 35.
19. Nishikibe, M., T. Fukuroda and A. Nakajima, 1989. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine. Arch. Int. Pharmacodyn. Ther. 297, 98.
20. Okamiya, Y., T. Kishimoto, K. Sunakawa, K. Aoki, H. Tanabe, T. Takeshita and T. Naruchi, 1992, Antihypertensive effect of the new calcium antagonist (±)3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats, Arzneim.-Forsch. 42, 9.
21. Opie, L.H., 1988, Calcium channel antagonists. Part V: Second-generation agents, Cardiovasc. Drugs Ther. 2, 191.
22. Pang, D.C. and N. Sperelakis, 1984, Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities, Biochem. Pharmacol. 33, 821.
23. Reicker-Reiss, H. and E. Barasch, 1991, Calcium antagonists in patients with heart failure. A review, Drugs 42, 343.
24. Rhodes, D.G., J.G. Sarmiento and L.G. Herbette, 1985, Kinetics of binding of membrane-active drugs to receptors. Diffusion limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol. Pharmacol. 27, 612.
25. Rodenkirchen, R., R. Bayer, R. Steiner, F. Bossert, H. Meyer and E. Moller, 1979, Structure-activity studies on nifedipine in isolated cardiac muscle. Naunyn-Schmied. Arch. Pharmacol. 310, 69.
26. 3H)nitrendipine in mammalian cardiac and smooth muscle membrane, Proc. Natl. Acad. Sci. USA 83, 7452.
27. Sanguinetti, M.C. and R.S. Kass, 1984, Voltage dependent block of calcium current in calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists, Circ. Res. 55, 336.
28. Sarmiento, J.G., R.A. Janis, A.M. Katz and D.J. Triggle, 1984, Comparison of high affinity binding of calcium channel blocking drugs to vascular smooth muscle and cardiac sarcolemmal membranes, Biochem. Pharmacol. 33, 3119.
29. Sorkin, E.M., S.P. Clissold and R.N. Brogdan, 1985, Nifedipine. A review of its pharmacodynamic and therapeutic efficacy, in iscaemic heart disease, hypertension and related cardiovascular disorders. Drugs 30, 182.
30. Tohse, N., 1990. Calcium-sensitive delayed rectifier potassium current in guinea pig ventricular cells. Am. J. Physiol. 258, H1200.
31. 2+ current by manidipine in guinea-pig heart cells, Eur. J. Pharmacol. 249, 231.
32. Van Amsterdam F.T., M. Haas and J. Zaagsma, 1987, Dynamic and kinetic differences of the vascular and myocardial effects of calcium antagonists in the rat heart, J. Cardiovasc. Pharmacol. 9, 570.
33. Vanhoutte, P.M. and R. Paoletti, 1987, The WHO classification of calcium antagonists, Trends Pharmacol. Sci. 8, 4.